Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 20 Dec 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

17 Dec 2024 According to a BioCardia media release, the company expecting final results by the end of the first quarter of 2025.
13 Nov 2024 According to a BioCardia media release,the company expecting topline data and submission to FDA and Japans PMDA in Q1 2025
13 Nov 2024 According to a BioCardia media release, the company intend to request a meeting with the FDA to discuss the results with respect to approvability of the CardiAMP Cell Therapy System .

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com